Skip to main content
OpenTrials
Completed

NCT Number: NCT02343419

Diagnostic Utility of Different Airway Resistance Assessment Techniques in the Methacholine Challenge Test

The aim of the study is to compare standard spirometric evaluation of methacholine challenge test with plethysmographic, interrupter technique and forced oscillation technique (FOT) evaluation of the airways resistance.

The study group will consist of patients referred for methacholine challenge test. All patient will undergo spirometric, plethysmographic, interrupter technique and FOT examinations - before and after inhalation of aerosols. Patients will also undergo the measurement of nitric oxide concentration in exhaled air and laboratory tests, including: blood count, measurement of serum C-reactive protein, sodium, potassium, creatinine, immunoglobulin E and N-Terminal pro-brain natriuretic peptide (NT-proBNP) concentration.

The investigators intend to assess, if plethysmographic, and/or interrupter, and/or FOT measurement of bronchial reactivity can replace standard spirometric assessment. Plethysmography, interrupter technique and FOT are much more easier to perform for patients. Furthermore, those two techniques are less dependent on patient's motivation and cooperation ability. Thus, usage of FOT, interrupter technique and/or plethysmography in bronchial hyperreactivity testing could make methacholine challenge test more comfortable and available for more patients. The investigators are also going to analyze the relationship between exhaled nitric oxide and functional indices of bronchial hyperreactivity.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Department of Internal Medicine, Pneumonology and Allergy, Medical University of Warsaw

Warsaw, Masovian Voivodeship, 02-097, Poland

About this study

Bronchial hyperreactivity is defined as the increased respiratory tract responsiveness to multiple stimuli, which results in bronchial muscles constriction and bronchial lumen narrowing. Bronchial hyperreactivity is a hallmark of asthma, however it may also be present in other diseases, e.g. chronic obstructive pulmonary disease (COPD). Methacholine challenge test is one of the bronchial reactivity assessment methods. Methacholine acts directly on bronchial smooth muscles receptors and causes bronchoconstriction. Bronchial reactivity is increased in the presence of active inflammation. Methacholine challenge testing is commonly performed in patients with symptoms suggestive of asthma and negative result of spirometry reversibility test. The measurement of methacholine concentration which causes 20% forced expiratory volume at one second (FEV1) decrease in post-inhalation spirometry (PC20) is a standard method of hyperreactivity evaluation. However, above method could be used among patients who are able to perform acceptable spirometry. Furthermore, results of spirometry might be influenced by level of compliance and motivation of patients. Moreover, whereas spirometric methacholine challenge test has high negative predictive values, its positive predictive value is relatively low. Thus, diagnostic utility of other pulmonary function tests should be assessed in methacholine challenge test evaluation.

In plethysmography airway resistance is performed during tidal breathing. The increase of specific airway resistance of 200% and the decrease of specific airway conductance of 40% after methacholine inhalation, respectively, are proposed as a cut-off levels for bronchial hyperreactivity diagnosis.

In forced oscillation technique (FOT), sinusoidal oscillations are emitted by membrane into airway lumen and airway resistance is calculated on the basis of changes in air flow induced by oscillations. The increase of resistance and decrease of reactance in FOT are typical for bronchoconstriction.

Finally, also interrupter technique (IT) allows for airway resistance assessment during tidal breathing. In IT, airway resistance is calculated on the basis of mouth pressure measured directly after airway occlusion and airflow measured directly before occlusion.

The aim of the study is to compare standard spirometric evaluation of methacholine challenge test with plethysmographic, interrupter technique and forced oscillation technique (FOT) evaluation of the airways resistance.

All patient will undergo:

  • clinical examination
  • measurement of nitric oxide concentration in exhaled air
  • spirometric, plethysmographic, interrupter technique and FOT examinations - before inhalation and after inhalation of aerosols
  • following laboratory tests: blood count, measurement of serum C-reactive protein (CRP), sodium, potassium, creatinine, immunoglobulin E and NT-proBNP concentration

Patients will be provided with written and spoken information about study protocol. Written informed consent will be obtained from every patient.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • presence of asthma symptoms without confirmation of diagnosis by standard methods
  • dyspnea and/or cough of unknown etiology

Exclusion criteria

  • FEV1 <1.2 L or <60% of predicted value
  • acute heart failure
  • myocardial infarction in last 3 months
  • transient ischaemic attack or stroke in last 3 months
  • aneurysms
  • methacholine allergy
  • pregnant and lactating women
  • administration of β2-mimetic, anticholinergic agent or theophylline before methacholine challenge test in 6, 8 and 24 hours, respectively
  • respiratory tract infection in last 6 weeks
  • patient inability to cooperate

Treatment and study plan

Methacholine Challenge Test

Other

Forced oscillation technique test, plethysmography, interrupter technique test and spirometry will be performed in a row before any intervention and after inhalation of aerosols - normal saline, followed by increasing concentrations of methacholine: 0.03 mg/ml; 0.06 mg/ml; 0.125 mg/ml; 0.25 mg/ml, 0.5 mg/ml, 1 mg/ml, 2 mg/ml, 4 mg/ml, 8 mg/ml, 16 mg/ml.

In case of FEV1 decrease of ≥ 20% of the initial value methacholine challenge test will be ceased and patient will be administered 200 µg of salbutamol in inhalation. Then, pulmonary function tests will be performed after 15 minutes.

Primary outcomes

  1. The concentration of methacholine inducing a 20% fall in FEV(1) from post-diluent baseline [PC(20)]

    Time frame: up to 2 hours

    In case of FEV1 decrease of > 20% from baseline PC (20) will be calculated by logarithmic interpolation.

Secondary outcomes

  1. Change in FOT resistance and reactance from post-diluent baseline after inhalating consecutive methacholine aerosols

    Time frame: within 6 minutes after methacholine aerosol inhalation

    Airway resistance and reactance will be measured by FOT after inhalating methacholine aerosols until FEV(1) fall of >20% from baseline

  2. Change in plethysmographic airway resistance from post-diluent baseline after inhalating consecutive methacholine aerosols

    Time frame: within 6 minutes after methacholine aerosol inhalation

    Airway resistance will be measured by plethysmography after inhalating methacholine aerosols until FEV(1) fall of >20% from baseline

  3. Change in interrupter airway resistance from post-diluent baseline after inhalating consecutive methacholine aerosols

    Time frame: within 6 minutes after methacholine aerosol inhalation

    Airway resistance will be measured by interrupter technique after inhalating methacholine aerosols until FEV(1) fall of >20% from baseline

  4. Change in FEV(1) from from post-diluent baseline after inhalating consecutive methacholine aerosols

    Time frame: within 6 minutes after methacholine aerosol inhalation

    FEV (1) will be measured by spirometry after inhalating methacholine aerosols until FEV(1) fall of >20% from baseline

  5. Assessment of the difficulty level of FOT

    Time frame: after methacholine challenge test (up to 2 hours two hours from the start of the methacholine challenge test)

    Patients will receive visual analogue scale form assessing difficulty level and problems related to performing each test

  6. Assessment of the difficulty level of plethysmography

    Time frame: after methacholine challenge test (up to 2 hours two hours from the start of the methacholine challenge test)

    Patients will receive visual analogue scale form assessing difficulty level and problems related to performing each test

  7. Assessment of the difficulty level of interrupter technique

    Time frame: after methacholine challenge test (up to 2 hours two hours from the start of the methacholine challenge test)

    Patients will receive visual analogue scale form assessing difficulty level and problems related to performing each test

  8. Assessment of the difficulty level of spirometry

    Time frame: after methacholine challenge test (up to 2 hours two hours from the start of the methacholine challenge test)

    Patients will receive visual analogue scale form assessing difficulty level and problems related to performing each test

  9. Duration of the bronchial resistance assessment by FOT

    Time frame: During methacholine challenge test (up to 2 hours)

    Duration of each pulmonary function test will be measured

  10. Duration of the bronchial resistance assessment by plethysmography

    Time frame: During methacholine challenge test (up to 2 hours)

    Duration of each pulmonary function test will be measured

  11. Duration of the bronchial resistance assessment by interrupter technique

    Time frame: During methacholine challenge test (up to 2 hours)

    Duration of each pulmonary function test will be measured

  12. Duration of spirometry

    Time frame: During methacholine challenge test (up to 2 hours)

    Duration of each pulmonary function test will be measured

  13. Total duration of methacholine challenge test

    Time frame: During methacholine challenge test (up to 2 hours)

    Total duration bronchial challenge will be measured

Other outcomes

  1. Measurement of nitric oxide concentration in exhaled air

    Time frame: Participanst will undergo measurement of nitric oxide concentration in exhaled air immediately before bronchial challenge test, total time of measurement: approximately 10 minutes

    Nitric oxide concentration in exhaled air will be measured once, immediately before performing methacholine challenge test

  2. Laboratory tests

    Time frame: Patients will undergo laboratory tests once before perfoming methacholine challenge test; maximum period between the methacholine challenge test and performing laboratory tests: one month

    Following laboratory tests will be performed: blood count, measurement of serum C-reactive protein, sodium, potassium, creatinine, immunoglobulin E and NT-proBNP concentration

Sponsors and collaborators

Lead sponsor

Medical University of Warsaw

Other

Registry information

Official study title

Diagnostic Utility of Different Airway Resistance Assessment Techniques in the Evaluation of Bronchial Hyperreactivity by Methacholine Challenge Testing

Important dates

Study start
2014
Primary completion
2016
Study completion
2016
First posted
Jan 22, 2015
Registry last updated
Nov 9, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.